Skip to main content
. Author manuscript; available in PMC: 2013 Apr 2.
Published in final edited form as: Arch Gen Psychiatry. 2012 Sep;69(9):973–981. doi: 10.1001/archgenpsychiatry.2012.1a

Figure 1.

Figure 1

Study flow diagram. NI+OP indicates 1000-mg naltrexone implantandoral placebo; PI+NO, placebo implant and 50-mg oral naltrexone hydrochloride; PI+OP, placebo implant and oral placebo. The 2 adverse events in the NI+OP group include wound infection only.